Artesunate is an antimalarial drug that is commonly used to treat severe cases of malaria. According to the sources provided, there is limited information on common allergies associated with the use of artesunate.

The first source, Drug Patent Watch [1], provides information on the patent status and expiration date of artesunate but does not mention any allergies associated with the drug.

The second source, a research article published in the National Center for Biotechnology Information [2], describes the safety and efficacy of artesunate in the treatment of malaria. The article mentions that artesunate is generally well-tolerated and has a low incidence of adverse effects. However, the article does not provide information on common allergies associated with the drug.

The third source, a review article published in Trends in Parasitology [3], discusses the current status and future prospects of artemisinin-based combination therapies (ACTs) for the treatment of malaria. The article mentions that ACTs, including artesunate, are generally safe and well-tolerated, but may cause allergic reactions in rare cases. However, the article does not provide information on the specific types of allergies associated with artesunate.

In summary, while the sources provided indicate that artesunate is generally safe and well-tolerated, there is limited information on common allergies associated with the drug. Patients who experience any adverse reactions while taking artesunate should consult their healthcare provider immediately.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/ARTESUNATE
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338243/
[3] https://www.cell.com/trends/parasitology/fulltext/S1471-4922(21)00224-5